MedTrace Logo

"Assessing Barriers to ADA Guideline Adherence"

NCT00503464 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2012-07-19

No results posted yet for this study

Summary

This project involves a comprehensive assessment of barriers to diabetes guidelines adherence across 25 practices in the Crozer-Keystone primary care PBRN. A Barrier Assessment Tool (BAT) will be validated to correlate with provider and practice adherence to diabetes care guidelines. The network is part of the Crozer-Keystone Health System located in Delaware County, Pennsylvania, in the southeast quadrant of the Philadelphia metropolitan region.

Conditions

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    lead FED

Principal Investigators

  • Mitchell A. Kaminski, M.D., M.B.A. · Crozer-Keystone Health Network

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00503464 on ClinicalTrials.gov